Sorrento Therapeutics, Inc. - Dec 2, 2022 Form 4 Insider Report for Scilex Holding Co (SCLX)

Role: 10%+ Owner
Signature: /s/ Henry Ji, Ph.D., President, Chief Executive Officer and Chairman of the Board, Sorrento Therapeutics, Inc.
Stock symbol: SCLX
Transactions as of: Dec 2, 2022
Transactions value $: $78,852
Form type: 4
Date filed: 12/2/2022, 06:21 PM
Previous filing: Nov 25, 2022
Next filing: Jan 23, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SCLX	Warrants to Purchase Common Stock	Purchase	$78.9K	+225K	+5.27%	$0.35	4.49M	Dec 2, 2022	Common Stock	225K	$11.50	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.32 to $0.36 per warrant, inclusive. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or a securityholder of the Issuer, full information regarding the number of warrants purchased at each separate price.

Content

The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.32 to $0.36 per warrant, inclusive. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or a securityholder of the Issuer, full information regarding the number of warrants purchased at each separate price.